Neumann Capital Management LLC Has $1.66 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Neumann Capital Management LLC lessened its position in shares of CVS Health Co. (NYSE:CVS) by 9.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,951 shares of the pharmacy operator’s stock after selling 3,980 shares during the quarter. Neumann Capital Management LLC’s holdings in CVS Health were worth $1,659,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the third quarter valued at about $25,000. Ridgewood Investments LLC grew its position in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the period. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the 3rd quarter valued at approximately $31,000. Legacy Investment Solutions LLC bought a new position in CVS Health during the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC bought a new stake in CVS Health in the third quarter valued at approximately $32,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

CVS opened at $53.87 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market cap of $67.79 billion, a price-to-earnings ratio of 13.67, a PEG ratio of 0.80 and a beta of 0.59. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The business has a 50 day moving average of $51.23 and a 200-day moving average of $56.24.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the previous year, the firm posted $2.21 EPS. CVS Health’s revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts expect that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.94%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio is 67.51%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. UBS Group boosted their price target on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Royal Bank of Canada lowered their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Evercore ISI increased their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research report on Tuesday, December 3rd. Finally, StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.